- Report
- August 2025
- 187 Pages
Global
From €3156EUR$3,545USD£2,758GBP
€3507EUR$3,939USD£3,064GBP
- Report
- August 2025
- 142 Pages
Global
From €3516EUR$3,950USD£3,072GBP
- Report
- April 2025
- 100 Pages
Canada
From €4407EUR$4,950USD£3,850GBP
- Report
- July 2024
- 120 Pages
Global
From €4228EUR$4,750USD£3,695GBP
- Report
- September 2025
- 96 Pages
Global
From €3500EUR$4,212USD£3,165GBP
- Report
- October 2025
- 50 Pages
Global
From €2359EUR$2,650USD£2,061GBP
Iodixanol is a non-ionic, low-osmolar contrast medium used in medical imaging. It is used to enhance the visibility of organs and tissues during X-ray, computed tomography (CT), and magnetic resonance imaging (MRI) scans. It is also used to diagnose and treat certain medical conditions. Iodixanol is a member of the class of contrast media known as iodinated contrast agents, which are used to improve the visibility of organs and tissues during imaging procedures.
Iodixanol is a safe and effective contrast medium that is well tolerated by patients. It is available in a variety of formulations, including injectable solutions, oral solutions, and suspensions. It is also available in a variety of concentrations, allowing for the adjustment of the dose to the patient's needs.
Iodixanol is widely used in medical imaging and is available from a number of manufacturers, including GE Healthcare, Bayer, Bracco, Guerbet, and Mallinckrodt. Show Less Read more